{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:42:28Z","timestamp":1791859348823,"version":"4.3.4"},"reference-count":227,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:p>The acquired depigmenting disorder of vitiligo affects an estimated 1% of the world population and constitutes one of the commonest dermatoses. Although essentially asymptomatic, the psychosocial impact of vitiligo can be severe. The cause of vitiligo remains enigmatic, hampering efforts at successful therapy. The underlying pathogenesis of the pigment loss has, however, been clarified to some extent in recent years, offering the prospect of effective treatment, accurate prognosis and rational preventative strategies. Vitiligo occurs when functioning melanocytes disappear from the epidermis. A single dominant pathway is unlikely to account for all cases of melanocyte loss in vitiligo; rather, it is the result of complex interactions of biochemical, environmental and immunological events, in a permissive genetic milieu. ROS (reactive oxygen species) and H2O2 in excess can damage biological processes, and this situation has been documented in active vitiligo skin. Tyrosinase activity is impaired by excess H2O2 through oxidation of methionine residues in this key melanogenic enzyme. Mechanisms for repairing this oxidant damage are also damaged by H2O2, compounding the effect. Numerous proteins and peptides, in addition to tyrosinase, are similarly affected. It is possible that oxidant stress is the principal cause of vitiligo. However, there is also ample evidence of immunological phenomena in vitiligo, particularly in established chronic and progressive disease. Both innate and adaptive arms of the immune system are involved, with a dominant role for T-cells. Sensitized CD8+ T-cells are targeted to melanocyte differentiation antigens and destroy melanocytes either as the primary event in vitiligo or as a secondary promotive consequence. There is speculation on the interplay, if any, between ROS and the immune system in the pathogenesis of vitiligo. The present review focuses on the scientific evidence linking alterations in ROS and\/or T-cells to vitiligo.<\/jats:p>","DOI":"10.1042\/cs20090603","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T14:13:45Z","timestamp":1287584025000},"page":"99-120","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Vitiligo, reactive oxygen species and T-cells"],"prefix":"10.1042","volume":"120","author":[{"given":"Steven\u00a0J.","family":"Glassman","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Ottawa, 737 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 1J8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"2021113010160711400_B1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst\u00a0Homan","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-4632.2007.03195.x","article-title":"Vitiligo: the historical curse of depigmentation","volume":"46","author":"Millington","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-4362.2000.00880.x","article-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","volume":"39","author":"Boisseau-Garsaud","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1346-8138.1999.tb02067.x","article-title":"Vitiligo: clinical findings in 1436 patients","volume":"26","author":"Handa","year":"1999","journal-title":"J. Dermatol."},{"key":"2021113010160711400_B6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1085-5629(97)80030-2","article-title":"Vitiligo","volume":"16","author":"Le\u00a0Poole","year":"1997","journal-title":"Semin. Cutan. Med. Surg."},{"key":"2021113010160711400_B7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B8","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1096\/fj.09-132621","article-title":"Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage","volume":"23","author":"Salem","year":"2009","journal-title":"FASEB J."},{"key":"2021113010160711400_B9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.8128228","article-title":"Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin","volume":"263","author":"Schallreuter","year":"1994","journal-title":"Science"},{"key":"2021113010160711400_B10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0749.2004.00145.x","article-title":"Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study","volume":"17","author":"De\u00a0Vijlder","year":"2004","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/archderm.1988.01670110009002","article-title":"Treatment of localized vitiligo by autologous minigrafting","volume":"124","author":"Falabella","year":"1988","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1610-0387.2007.06280.x","article-title":"Current state of vitiligo therapy-evidence-based analysis of the literature","volume":"5","author":"Forschner","year":"2007","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"2021113010160711400_B14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-4632.2004.02329.x","article-title":"Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy","volume":"44","author":"Kanwar","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1808-8694(15)30841-7","article-title":"A study on otoacoustic emissions and suppression effects in patients with vitiligo","volume":"75","author":"Angrisani","year":"2009","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"2021113010160711400_B17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0378-6323.32708","article-title":"Vitiligo: Compendium of clinico-epidemiological features","volume":"73","author":"Sehgal","year":"2007","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"2021113010160711400_B18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sder.2009.04.008","article-title":"Vitiligo update","volume":"28","author":"Halder","year":"2009","journal-title":"Semin. Cutan. Med. Surg."},{"key":"2021113010160711400_B19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJMcp0804388","article-title":"Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021113010160711400_B20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.1967.01610030083015","article-title":"The evolution of concepts of melanin biology","volume":"96","author":"Fitzpatrick","year":"1967","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/sita.200600102","article-title":"Role of cyclic GMP signaling in the melanocyte response to hypergravity","volume":"6","author":"Ivanova","year":"2006","journal-title":"Signal Transduct."},{"key":"2021113010160711400_B23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/1011-1344(91)80147-A","article-title":"Photoprotection by melanin","volume":"9","author":"Kollias","year":"1991","journal-title":"J. Photochem. Photobiol. B."},{"key":"2021113010160711400_B24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1523-1747.1998.00178.x","article-title":"Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis","volume":"110","author":"Kobayashi","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B25","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le\u00a0Poole","year":"1993","journal-title":"J. Immunol."},{"key":"2021113010160711400_B26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000131485","article-title":"Autoimmune etiology of generalized vitiligo","volume":"10","author":"Le\u00a0Poole","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"key":"2021113010160711400_B27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1471-4906(00)01844-5","article-title":"A symbiotic concept of autoimmunity and tumor immunity: lessons from vitiligo","volume":"22","author":"Das","year":"2001","journal-title":"Trends Immunol."},{"key":"2021113010160711400_B28","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI31942","article-title":"Lymphocytes, neuropeptides, and genes involved in alopecia areata","volume":"117","author":"Gilhar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2021113010160711400_B29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1468-3083.2009.03233.x","article-title":"The hair follicle melanocytes in vitiligo in relation to disease duration","volume":"23","author":"Anbar","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.1538","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M","volume":"202","author":"Kitamura","year":"2004","journal-title":"J. Pathol."},{"key":"2021113010160711400_B31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.10.001","article-title":"Physiopathology and genetics of vitiligo","volume":"25","author":"Passerson","year":"2005","journal-title":"J. Autoimmun."},{"key":"2021113010160711400_B32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell'Anna","year":"2006","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-0749.2007.00399.x","article-title":"Vitiligo puzzle: the pieces fall in place","volume":"20","author":"Westerhof","year":"2007","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666_1.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Exp. Dermatol."},{"key":"2021113010160711400_B35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1600-0625.2008.00826.x","article-title":"Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff","volume":"18","author":"Boissy","year":"2009","journal-title":"Exp. Dermatol."},{"key":"2021113010160711400_B36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le\u00a0Poole","year":"1993","journal-title":"Exp. Dermatol."},{"key":"2021113010160711400_B37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0749.2007.00408.x","article-title":"Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected?","volume":"20","author":"Namazi","year":"2007","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B40","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol. Histopathol."},{"key":"2021113010160711400_B41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000131501","article-title":"The genetics of generalized vitiligo","volume":"10","author":"Spritz","year":"2008","journal-title":"Curr. Opin. Autoimmun."},{"key":"2021113010160711400_B42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/jid.2009.273","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1)","volume":"130","author":"Jin","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-0749.2002.00057.x","article-title":"Genetic association of the Catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp","year":"2002","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B44","first-page":"146","article-title":"Might there be a link between mannose-binding lectin and vitiligo","volume":"17","author":"Onay","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"2021113010160711400_B45","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/jid.2009.143","article-title":"Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population","volume":"129","author":"Liu","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B46","doi-asserted-by":"crossref","first-page":"e1000523","DOI":"10.1371\/journal.pgen.1000523","article-title":"Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo","volume":"5","author":"Ren","year":"2009","journal-title":"PLoS Genet."},{"key":"2021113010160711400_B47","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N. Eng. J. Med."},{"key":"2021113010160711400_B48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ng.411","article-title":"Genome-wide association study identifies three loci associated with melanoma risk","volume":"41","author":"Bishop","year":"2009","journal-title":"Nat. Genet."},{"key":"2021113010160711400_B49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","article-title":"Vitiligo: a manifestation of apoptosis?","volume":"3","author":"Huang","year":"2002","journal-title":"Am. J. Clin. Dermatol."},{"key":"2021113010160711400_B50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2249.2003.02104.x","article-title":"Oxygen free radicals and systemic autoimmunity","volume":"131","author":"Ahsan","year":"2003","journal-title":"Clin. Exp. Imunol."},{"key":"2021113010160711400_B51","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am. J. Physiol."},{"key":"2021113010160711400_B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2190001","article-title":"Oxygen toxicity, oxygen radicals, transition metals and disease","volume":"219","author":"Halliwell","year":"1984","journal-title":"Biochem. J."},{"key":"2021113010160711400_B53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1126\/science.3810154","article-title":"Oxygen free radicals linked to many diseases","volume":"235","author":"Marx","year":"1987","journal-title":"Science"},{"key":"2021113010160711400_B54","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1126\/science.3287616","article-title":"DNA damage and oxygen radical toxicity","volume":"240","author":"Imlay","year":"1988","journal-title":"Science"},{"key":"2021113010160711400_B55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/03602539808996315","article-title":"DNA damage by iron and hydrogen peroxide in vitro and in vivo","volume":"30","author":"Linn","year":"1998","journal-title":"Drug Metab. Rev."},{"key":"2021113010160711400_B56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-6-4","article-title":"Cytochrome-P450 enzymes and autoimmunity: expansion of the relationship and introduction of free radicals as the link","volume":"6","author":"Namazi","year":"2009","journal-title":"J. Autoimmun. Dis."},{"key":"2021113010160711400_B57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2133.2009.09288.x","article-title":"Decreased methionine sulfoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo","volume":"161","author":"Zhou","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.jid.5700116","article-title":"The repair enzyme peptide methionine-S-sulfoxide reductase is expressed in human epidermis and upregulated by UVA radiation","volume":"126","author":"Ogawa","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B59","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.91.23.10771","article-title":"Oxidative damage and mitochondrial decay in aging","volume":"91","author":"Shigenaga","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2021113010160711400_B60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1468-3083.2003.00751.x","article-title":"Antioxidant activity, lipid peroxidation and skin diseases. What's new","volume":"17","author":"Briganti","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B61","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/sj.jid.5700340","article-title":"Oxidative stress in the pathogenesis of skin disease","volume":"126","author":"Bickers","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B62","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.08-125435","article-title":"Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair","volume":"23","author":"Wood","year":"2009","journal-title":"FASEB J."},{"key":"2021113010160711400_B63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"2021113010160711400_B64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","article-title":"Low catalase levels in the epidermis of patients with vitiligo","volume":"97","author":"Schallreuter","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/1523-1747.ep12500086","article-title":"Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo","volume":"79","author":"Moellmann","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0560.1983.tb00328.x","article-title":"Keratinocyte damage in vitiligo","volume":"10","author":"Bhawan","year":"1983","journal-title":"J. Cutan. Pathol."},{"key":"2021113010160711400_B67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12480976","article-title":"Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients","volume":"97","author":"Boissy","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","article-title":"Melanocytes are not absent in lesional skin of long duration vitiligo","volume":"191","author":"Tobin","year":"2000","journal-title":"J. Pathol."},{"key":"2021113010160711400_B69","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jrs.1968","article-title":"Identification of epidermal L-tryptophan and its oxidation products by in vivo FT-Raman spectroscopy further supports oxidative stress in patients with vitiligo","volume":"39","author":"Rokos","year":"2008","journal-title":"J. Raman. Spectrosc."},{"key":"2021113010160711400_B70","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1600-0625.2008.00697.x","article-title":"Presence of epidermal allantoin further supports oxidative stress in vitiligo","volume":"17","author":"Shalbaf","year":"2008","journal-title":"Exp. Dermatol."},{"key":"2021113010160711400_B71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2230.2004.01524.x","article-title":"Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo","volume":"29","author":"Koca","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"2021113010160711400_B72","first-page":"297","article-title":"Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11\u201320 years","volume":"52","author":"Jain","year":"2008","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"2021113010160711400_B73","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00403-009-0964-4","article-title":"Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo","volume":"301","author":"Khan","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"2021113010160711400_B74","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1523-1747.ep12374036","article-title":"Free radicals in cutaneous biology","volume":"102","author":"Darr","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B75","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1096\/fj.99-0878com","article-title":"Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-\u03b21","volume":"14","author":"Thannickal","year":"2000","journal-title":"FASEB J."},{"key":"2021113010160711400_B76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02505037","article-title":"Increased monoamine oxidase A activity in the epidermis of patients with vitiligo","volume":"288","author":"Schallreuter","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"2021113010160711400_B77","first-page":"943","article-title":"A review of recent advances on the regulation of pigmentation in the human epidermis","volume":"45","author":"Schallreuter","year":"1999","journal-title":"Cell Mol. Biol."},{"key":"2021113010160711400_B78","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.jid.5700257","article-title":"Estrogens can contribute to hydrogen peroxide generation and quinone-mediated DNA damage in peripheral blood lymphocytes from patients with vitiligo","volume":"126","author":"Schallreuter","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1523-1747.2001.00220.x","article-title":"Epidermal H2O2 accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes?","volume":"116","author":"Schallreuter","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B80","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/bbrc.2002.6727","article-title":"Oxidative stress in vitiligo: photo-oxidation of pterins produces H2O2 and pterin-6-carboxylic acid","volume":"292","author":"Rokos","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010160711400_B81","first-page":"720","article-title":"Is there a relationship between homocysteine and vitiligo? A pilot study","volume":"159","author":"Shaker","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B82","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0749.1994.tb00034.x","article-title":"Antioxidant status in the blood of patients with active vitiligo","volume":"7","author":"Picardo","year":"1994","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1468-3083.2004.01080.x","article-title":"The role of oxidants and antioxidants in generalized vitiligo at tissue level","volume":"18","author":"Yildirim","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B84","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-4632.2004.02027.x","article-title":"A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients","volume":"44","author":"Hazneci","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-4632.2009.03998.x","article-title":"Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo","volume":"48","author":"Dammak","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/9780470760116.ch32","article-title":"Chemical leukoderma","volume-title":"Vitiligo: a Comprehensive Monograph on Basic and Clinical Science","author":"Miyamoto","year":"2000"},{"key":"2021113010160711400_B87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-0749.2000.130107.x","article-title":"Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tertbutylphenol and 4-tert-butylcatechol","volume":"13","author":"Thorneby-Andresson","year":"2000","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B88","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","article-title":"Mechanism of depigmentation by hydroquinone","volume":"62","author":"Jimbow","year":"1974","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B89","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/1046-199X(95)90112-4","article-title":"Chemical leukoderma: fact or fancy","volume":"6","author":"Cummings","year":"1995","journal-title":"Am. J. Contact Dermatitis"},{"key":"2021113010160711400_B90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0749.13.s8.9.x","article-title":"Intrinsic and extrinsic pathomechanisms in vitiligo","volume":"13","author":"Ta\u00efeb","year":"2000","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B91","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\/occupational vitiligo","volume":"17","author":"Boissy","year":"2004","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B92","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1021\/tx900018q","article-title":"A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity","volume":"22","author":"Manini","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"2021113010160711400_B93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jid.2009.214","article-title":"Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation","volume":"130","author":"Hariharan","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B94","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1365-2133.2007.08406.x","article-title":"Proton pump inhibitors may trigger vitiligo by rendering melanocytes prone to apoptosis","volume":"158","author":"Namazi","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B95","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1365-2133.2007.07870.x","article-title":"From the bench to the bedside: proton pump inhibitors can worsen vitiligo","volume":"156","author":"Schallreuter","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0749.1992.tb00003.x","article-title":"Catecholamines and vitiligo","volume":"5","author":"Morrone","year":"1992","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B97","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00372012","article-title":"Increased in vitro expression of \u03b22-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients","volume":"285","author":"Schallreuter","year":"1993","journal-title":"Arch. Dermatol. Res."},{"key":"2021113010160711400_B98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0925-4439(94)90027-2","article-title":"Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo","volume":"1226","author":"Schallreuter","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010160711400_B99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10545-008-0971-1","article-title":"H2O2 increases de novo synthesis of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin via GTP cyclohydrolase I and its feedback regulatory protein in vitiligo","volume":"32","author":"Chavan","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"2021113010160711400_B100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2230.1998.00384.x","article-title":"Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology","volume":"23","author":"Papadopoulos","year":"1998","journal-title":"Clin. Exp. Dermatol."},{"key":"2021113010160711400_B101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Th\u00f6ny","year":"2000","journal-title":"Biochem. J."},{"key":"2021113010160711400_B102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.0022-202X.2004.22230.x","article-title":"Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress","volume":"122","author":"Hasse","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B103","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1997.8107","article-title":"In vivo evidence for compromised phenylalanine metabolism in vitiligo","volume":"243","author":"Schallreuter","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010160711400_B104","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00370732","article-title":"Catechol-O-methyl transferase in vitiligo","volume":"286","author":"Le\u00a0Poole","year":"1994","journal-title":"Arch. Dermatol. Res."},{"key":"2021113010160711400_B105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1740-2557-2-11","article-title":"Phenytoin as a novel anti-vitiligo weapon","volume":"2","author":"Namazi","year":"2005","journal-title":"J. Autoimmun. Dis."},{"key":"2021113010160711400_B106","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/sj.jid.5700612","article-title":"Computer simulation of native epidermal structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls","volume":"126","author":"Gibbons","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B107","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2004.01.082","article-title":"Activation\/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem","volume":"315","author":"Schallreuter","year":"2004","journal-title":"Biophys. Res. Commun."},{"key":"2021113010160711400_B108","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2007.02.078","article-title":"Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates","volume":"355","author":"Schallreuter","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010160711400_B109","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1749-6632.1999.tb08715.x","article-title":"The expression of alpha-MSH by melanocytes is reduced in vitiligo","volume":"885","author":"Graham","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2021113010160711400_B110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/joe.1.06275","article-title":"A novel mechanism in control of human pigmentation by \u03b2-melanocyte-stimulating hormone and 7-tetrahydrobiopterin","volume":"187","author":"Spencer","year":"2005","journal-title":"J. Endocrinol."},{"key":"2021113010160711400_B111","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.jid.5700538","article-title":"Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo","volume":"127","author":"Spencer","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jrs.1114","article-title":"In vivo fluorescence excitation spectroscopy and in vivo Fourier-transform Raman spectroscopy in human skin: evidence of H2O2 oxidation of epidermal albumin in patients with vitiligo","volume":"35","author":"Rokos","year":"2004","journal-title":"J. Raman Spectrosc."},{"key":"2021113010160711400_B113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2007.05.218","article-title":"Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo","volume":"360","author":"Schallreuter","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010160711400_B114","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1210\/en.2007-1317","article-title":"The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-medaited oxidation in vitiligo","volume":"149","author":"Spencer","year":"2008","journal-title":"Endocrinology"},{"key":"2021113010160711400_B115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1523-1747.2001.01290.x","article-title":"The paracrine role of stem cell factor\/c-kit signaling in the activation of human melanocytes in ultraviolet B-induced pigmentation","volume":"116","author":"Hachiya","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B116","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj3140305","article-title":"Signaling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes","volume":"314","author":"Imokawa","year":"1996","journal-title":"Biochem. J."},{"key":"2021113010160711400_B117","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1242\/jcs.114.12.2335","article-title":"Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor","volume":"114","author":"Jimenez-Cervantes","year":"2001","journal-title":"J. Cell Sci."},{"key":"2021113010160711400_B118","first-page":"704","article-title":"The importance of Koebner's phenomenon in the induction of vitiligo lesions","volume":"5","author":"Gauthier","year":"1996","journal-title":"Eur. J. Dermatol."},{"key":"2021113010160711400_B119","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1016\/j.biocel.2005.05.013","article-title":"Mitochondria in homeostasis of reactive oxygen species in cell, tissues and organism","volume":"37","author":"Jezek","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2021113010160711400_B120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/med.20146","article-title":"New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo","volume":"29","author":"Birlea","year":"2009","journal-title":"Medicinal Res. Rev."},{"key":"2021113010160711400_B121","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.bbrc.2004.10.185","article-title":"Regulation of tyrosinase by tetrahydropteridines and H2O2","volume":"325","author":"Wood","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010160711400_B122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin","volume":"75","author":"Sravani","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"2021113010160711400_B124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0625.2008.00699.x","article-title":"Computer simulation of heterogeneous single nucleotide polymorphisms in the catalase gene indicates structural changes in the enzyme active site, NADPH-binding and tetramerization domains: a genetic predisposition for an altered catalase in patients with vitiligo?","volume":"17","author":"Wood","year":"2008","journal-title":"Exp. Dermatol."},{"key":"2021113010160711400_B125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5701100","article-title":"Methionine sulfoxide reductases A and B are deactivated by hydrogen peroxide (H2O2) in the epidermis of patients with vitiligo","volume":"128","author":"Schallreuter","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0749.1998.tb00714.x","article-title":"Epidermal oxidative stress in vitiligo","volume":"11","author":"Passi","year":"1998","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2133.1999.02980.x","article-title":"Serum selenium levels and blood glutathione peroxidase activities in vitiligo","volume":"141","author":"Beazley","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B128","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-4362.2002.01472.x","article-title":"Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo","volume":"41","author":"Boisseau-Garsaud","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/014107688908200911","article-title":"Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper","volume":"82","author":"Slominski","year":"1989","journal-title":"J. R. Soc. Med."},{"key":"2021113010160711400_B130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.2007_3264","article-title":"Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions","volume":"54","author":"Reiter","year":"2007","journal-title":"Acta Biochim. Pol."},{"key":"2021113010160711400_B131","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"2021113010160711400_B132","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1242\/jcs.114.4.677","article-title":"Protective role of Bcl-2 in metabolic oxidative stress-induced cell death","volume":"114","author":"Lee","year":"2001","journal-title":"J. Cell Sci."},{"key":"2021113010160711400_B133","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2000.03712.x","article-title":"Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo","volume":"143","author":"Van\u00a0den\u00a0Wijngaard","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B134","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-4632.2008.03660.x","article-title":"From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo","volume":"47","author":"Schallreuter","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B135","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B136","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A randomized double-blinded placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B137","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind, randomized trial of 005% betamethasone vs topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B138","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"2021113010160711400_B139","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association","volume":"188","author":"Schallreuter","year":"1994","journal-title":"Dermatology"},{"key":"2021113010160711400_B141","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B142","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondyloarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2021113010160711400_B143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0190-9622(83)80279-5","article-title":"Association of HLA-DR4 with vitiligo","volume":"38","author":"Foley","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B144","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364016","article-title":"Genes of the LMP\/TAP cluster are associated with the human autoimmune disease vitiligo","volume":"4","author":"Casp","year":"2003","journal-title":"Genes Immun."},{"key":"2021113010160711400_B145","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/1523-1747.ep12614826","article-title":"Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo","volume":"99","author":"Venneker","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B146","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","article-title":"CTLA-4 polymorphisms are associated with vitiligo in patients with concomitant autoimmune diseases","volume":"18","author":"Blomhoff","year":"2005","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B147","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2133.2006.07166.x","article-title":"Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome","volume":"154","author":"Collins","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B148","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.gene.6364243","article-title":"A single nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalized vitiligo","volume":"6","author":"Cant\u00f3n","year":"2005","journal-title":"Genes Immun."},{"key":"2021113010160711400_B149","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"2021113010160711400_B150","first-page":"1529","article-title":"Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens","volume":"146","author":"Austin","year":"1995","journal-title":"Am. J. Pathol."},{"key":"2021113010160711400_B151","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1468-3083.2005.01295.x","article-title":"Assessment of the immune system in 55 Iranian patients with vitiligo","volume":"19","author":"Farrokhi","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B152","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B153","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo cells","volume":"5","author":"Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev."},{"key":"2021113010160711400_B154","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10354-009-0699-z","article-title":"Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+\/CD8+ T-cell ratio","volume":"159","author":"Pichler","year":"2009","journal-title":"Wien. Med. Wochenschr."},{"key":"2021113010160711400_B155","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1399-3046.2008.01093.x","article-title":"Possible transfer of vitiligo by allogeneic bone marrow transplantation: a case report","volume":"13","author":"Mellouli","year":"2009","journal-title":"Pediatr. Transplant."},{"key":"2021113010160711400_B156","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00447159","article-title":"T and B lymphocytes in vitiligo","volume":"261","author":"Ortonne","year":"1978","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B157","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0190-9622(86)70021-2","article-title":"T cell profiles in vitiligo","volume":"14","author":"Grimes","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B158","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1985.tb15640.x","article-title":"Vitiligo: peripheral T-cell subset imbalance as defined by monoclonal antibodies","volume":"113","author":"Soubiran","year":"1985","journal-title":"Br J. Dermatol."},{"key":"2021113010160711400_B159","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0190-9622(86)70085-6","article-title":"Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-4362.1993.tb04269.x","article-title":"Peripheral blood lymphocyte imbalance in Koreans with active vitiligo","volume":"32","author":"Hann","year":"1993","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B161","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-4362.1992.tb03946.x","article-title":"Nonsegmental vitiligo: decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation","volume":"31","author":"Abdel-Naser","year":"1992","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1346-8138.2002.tb00168.x","article-title":"Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+, CD45RO+ and CD4+ CD25+ T-helper cells in non-segmental vitiligo","volume":"29","author":"Mahmoud","year":"2002","journal-title":"J. Dermatol."},{"key":"2021113010160711400_B163","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1468-3083.2008.02681.x","article-title":"Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study","volume":"22","author":"Basak","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B164","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-\u03b1 and IFN-\u03b3 release by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Tu","year":"1999","journal-title":"J. Dermatol. Sci."},{"key":"2021113010160711400_B166","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B167","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0923-1811(02)00151-2","article-title":"Increased interleukin-6 and granulocyte macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo","volume":"31","author":"Tu","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"2021113010160711400_B168","first-page":"71","article-title":"Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo: relationship with type and extent of the disease","volume":"12","author":"Franczuk","year":"2004","journal-title":"Acta Dermatovenereol. Croat."},{"key":"2021113010160711400_B169","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B170","first-page":"799","article-title":"Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med. J."},{"key":"2021113010160711400_B171","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor \u03b1 (TNF-\u03b1) and interleukin 1\u03b1 (IL1-\u03b1) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B172","first-page":"74","article-title":"Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod","volume":"33","author":"Mashiah","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"2021113010160711400_B173","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","article-title":"Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus","volume":"161","author":"Taher","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"2021113010160711400_B174","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","article-title":"The role of helper and regulatory T cells in the pathogenesis of vitiligo","volume":"60","author":"Basak","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-4362.1983.tb02178.x","article-title":"Histopathology of vitiliginous skin","volume":"22","author":"Gokhale","year":"1983","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B176","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1346-8138.1992.tb03211.x","article-title":"Epidermal changes in active vitiligo","volume":"19","author":"Hann","year":"1992","journal-title":"J. Dermatol."},{"key":"2021113010160711400_B177","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ijd.1993.32.4.269","article-title":"Ultrastructural study of vitiligo","volume":"32","author":"Galadari","year":"1993","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0749.1994.tb00013.x","article-title":"Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo","volume":"7","author":"Abdel-Naser","year":"1994","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B179","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-4362.1988.tb02376.x","article-title":"The lichenoid tissue reaction","volume":"27","author":"Shiohara","year":"1988","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B180","first-page":"277","article-title":"Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo","volume":"2","author":"Gross","year":"1987","journal-title":"Histol. Histopathol."},{"key":"2021113010160711400_B181","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711690205","article-title":"Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo","volume":"169","author":"Al\u00a0Badri","year":"1993","journal-title":"J. Pathol."},{"key":"2021113010160711400_B182","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J. Pathol."},{"key":"2021113010160711400_B183","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van\u00a0den\u00a0Wijngaard","year":"2000","journal-title":"Lab. Invest."},{"key":"2021113010160711400_B184","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4049\/jimmunol.161.3.1220","article-title":"Human melanomareactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas\/Fas ligandindependent mechanisms for tumor killing","volume":"161","author":"Rivoltini","year":"1998","journal-title":"J. Immunol."},{"key":"2021113010160711400_B185","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol. Histopathol."},{"key":"2021113010160711400_B186","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.162.12.7140","article-title":"Crosstalk between keratinocytes and T lymphocytes via Fas\/Fas ligand interaction: modulation by cytokines","volume":"162","author":"Arnold","year":"1999","journal-title":"J. Immunol."},{"key":"2021113010160711400_B187","first-page":"158","article-title":"Vitiligo with raised borders","volume":"48","author":"Michaelsson","year":"1968","journal-title":"Acta Derm. Venereol."},{"key":"2021113010160711400_B188","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-4632.2008.03672.x","article-title":"Lichenoid inflammation in vitiligo \u2013 a clinical and histopathologic review of 210 cases","volume":"47","author":"Attili","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B189","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le\u00a0Poole","year":"1996","journal-title":"Am. J. Pathol."},{"key":"2021113010160711400_B190","first-page":"19","article-title":"Vitiligo with raised inflammatory borders: involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules","volume":"7","author":"Yagi","year":"1997","journal-title":"Eur. J. Dermatol."},{"key":"2021113010160711400_B191","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska","year":"2003","journal-title":"Lab. Invest."},{"key":"2021113010160711400_B192","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08916939708994728","article-title":"Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo","volume":"25","author":"Shresta","year":"1997","journal-title":"Autoimmunity"},{"key":"2021113010160711400_B193","first-page":"140","article-title":"In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis","volume":"65","author":"Del\u00a0Prete","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"2021113010160711400_B194","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1172\/JCI116835","article-title":"Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients","volume":"92","author":"Itoh","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2021113010160711400_B195","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le\u00a0Poole","year":"1993","journal-title":"J. Immunol."},{"key":"2021113010160711400_B196","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI3125","article-title":"Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy","volume":"102","author":"Comabella","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2021113010160711400_B197","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"2021113010160711400_B198","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B199","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch. Dermatol."},{"key":"2021113010160711400_B200","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-4362.1996.tb00654.x","article-title":"Vitiligo associated with metastatic malignant melanoma","volume":"35","author":"Cavallari","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"2021113010160711400_B201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"key":"2021113010160711400_B202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor-lysate pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"2021113010160711400_B203","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J. Exp. Med."},{"key":"2021113010160711400_B204","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"2021113010160711400_B205","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1073\/pnas.1533209100","article-title":"Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma","volume":"100","author":"Phan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010160711400_B206","doi-asserted-by":"crossref","first-page":"8978","DOI":"10.1200\/JCO.2005.01.6816","article-title":"Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients","volume":"23","author":"Luiten","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"2021113010160711400_B207","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.177.4.989","article-title":"Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients","volume":"177","author":"Anichini","year":"1993","journal-title":"J. Exp. Med."},{"key":"2021113010160711400_B208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002371-200001000-00004","article-title":"Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma","volume":"23","author":"Kawakami","year":"2000","journal-title":"J. Immunother."},{"key":"2021113010160711400_B209","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma","volume":"113","author":"Becker","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of na\u00efve Melan-A\/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J. Exp. Med."},{"key":"2021113010160711400_B211","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<538::AID-IJC16>3.0.CO;2-G","article-title":"Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides","volume":"86","author":"J\u00e4ger","year":"2000","journal-title":"Int. J. Cancer"},{"key":"2021113010160711400_B212","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"2021113010160711400_B213","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skinhoming melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J. Exp. Med."},{"key":"2021113010160711400_B214","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B215","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","article-title":"Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"121","author":"Mandelcorn-Monson","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B216","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/eji.200535110","article-title":"Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo","volume":"35","author":"Palermo","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"2021113010160711400_B217","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0749.2005.00244.x","article-title":"Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?","volume":"18","author":"Garbelli","year":"2005","journal-title":"Pigment Cell Res."},{"key":"2021113010160711400_B218","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"Van\u00a0den\u00a0Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B219","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2021113010160711400_B220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Degaco","year":"2006","journal-title":"Immunology"},{"key":"2021113010160711400_B221","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"2021113010160711400_B222","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.170.3.1304","article-title":"Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance","volume":"170","author":"Min","year":"2003","journal-title":"J. Immunol."},{"key":"2021113010160711400_B223","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"2021113010160711400_B224","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4 T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J. Immunol."},{"key":"2021113010160711400_B225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"2021113010160711400_B226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Aflazi","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"2021113010160711400_B227","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2006-07-034066","article-title":"CTLA-4 dysregulation of self\/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent","volume":"108","author":"Gattinoni","year":"2006","journal-title":"Blood"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/120\/3\/99\/441623\/cs1200099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/120\/3\/99\/441623\/cs1200099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T14:23:14Z","timestamp":1711894994000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/120\/3\/99\/68801\/Vitiligo-reactive-oxygen-species-and-T-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":227,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20090603","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,20]]}}}